Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2016 - 2025)

Vanda Pharmaceuticals' Asset Utilization Ratio history spans 14 years, with the latest figure at 0.4 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 29.79% year-over-year to 0.4; the TTM value through Dec 2025 reached 0.4, up 29.79%, while the annual FY2025 figure was 0.38, 23.86% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.4 at Vanda Pharmaceuticals, up from 0.35 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.47 in Q1 2021 and bottomed at 0.27 in Q1 2024.
  • The 5-year median for Asset Utilization Ratio is 0.38 (2023), against an average of 0.37.
  • The largest annual shift saw Asset Utilization Ratio crashed 32.0% in 2024 before it increased 29.79% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.46 in 2021, then fell by 11.54% to 0.41 in 2022, then dropped by 26.27% to 0.3 in 2023, then grew by 2.29% to 0.31 in 2024, then rose by 29.79% to 0.4 in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Asset Utilization Ratio are 0.4 (Q4 2025), 0.35 (Q3 2025), and 0.32 (Q2 2025).